- Home
- GTEC vs TPST Comparison
GTEC vs TPST Comparison
Compare GTEC & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- TPST
- Stock Information
- Founded
- GTEC 2006
- TPST 2011
- Country
- GTEC United States
- TPST United States
- Employees
- GTEC N/A
- TPST N/A
- Industry
- GTEC Industrial Machinery/Components
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- TPST Health Care
- Exchange
- GTEC Nasdaq
- TPST Nasdaq
- Market Cap
- GTEC 33.0M
- TPST 27.2M
- IPO Year
- GTEC N/A
- TPST N/A
- Fundamental
- Price
- GTEC $2.01
- TPST $0.70
- Analyst Decision
- GTEC
- TPST Strong Buy
- Analyst Count
- GTEC 0
- TPST 4
- Target Price
- GTEC N/A
- TPST $20.00
- AVG Volume (30 Days)
- GTEC 79.1K
- TPST 1.4M
- Earning Date
- GTEC 11-14-2024
- TPST 11-12-2024
- Dividend Yield
- GTEC N/A
- TPST N/A
- EPS Growth
- GTEC N/A
- TPST N/A
- EPS
- GTEC N/A
- TPST N/A
- Revenue
- GTEC $87,352,614.00
- TPST N/A
- Revenue This Year
- GTEC N/A
- TPST N/A
- Revenue Next Year
- GTEC $1.70
- TPST N/A
- P/E Ratio
- GTEC N/A
- TPST N/A
- Revenue Growth
- GTEC 0.76
- TPST N/A
- 52 Week Low
- GTEC $1.36
- TPST $0.70
- 52 Week High
- GTEC $3.84
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- GTEC 38.07
- TPST 24.08
- Support Level
- GTEC $2.01
- TPST $0.86
- Resistance Level
- GTEC $2.15
- TPST $0.86
- Average True Range (ATR)
- GTEC 0.12
- TPST 0.07
- MACD
- GTEC -0.00
- TPST -0.01
- Stochastic Oscillator
- GTEC 27.42
- TPST 0.00
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.